Frost & Sullivan Recognizes Eseye for Its Best-in-Class IoT Product Innovation
Oct 31, 2017 10:57 am UTC| Business
Austin TX, Oct. 31, 2017 -- Frost Sullivan has announced that Eseye, a global provider of machine-to-machine (M2M) cellular connectivity for Internet of Things (IoT) devices, is the European winner of the 2017 Product...
II-VI Incorporated Reports Fiscal Year 2018 First Quarter Earnings
Oct 31, 2017 10:55 am UTC| Business
Revenues of $262M increased 18% compared to Q1 FY17GAAP EPS of $0.32 increased 23% compared to Q1 FY17Adjusted EPS of $0.35 increased 35% compared to Q1 FY17 PITTSBURGH, Oct. 31, 2017 -- II-VI Incorporated...
Washington’s First Road Usage Charge Project Awarded to IMS with Partner A-to-Be
Oct 31, 2017 10:55 am UTC| Business
Waterloo, Ontario, Canada, Oct. 31, 2017 -- Intelligent Mechatronic Systems (IMS) a leading connected car services and analytics provider to governments, insurers and enterprises, was awarded Washington state’s first...
Ritter Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
Oct 31, 2017 10:45 am UTC| Business
LOS ANGELES, Oct. 31, 2017 -- Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (“Ritter Pharmaceuticals” or the “Company”), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome...
Oct 31, 2017 10:45 am UTC| Business
VIRGINIA CITY, Nev., Oct. 31, 2017 -- Comstock Mining Inc. (the “Company”) (NYSE American:LODE) today reported selected unaudited financial results for the fiscal quarter ended September 30, 2017, and business...
TransUnion Announces Pricing of Secondary Offering of 7,535,107 Shares of Common Stock
Oct 31, 2017 10:45 am UTC| Business
CHICAGO, Oct. 31, 2017 -- TransUnion (the “Company”) (NYSE:TRU) announced the pricing of the underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”) of 7,535,107 shares of common...
Oct 31, 2017 10:45 am UTC| Business
Quarter highlighted by data presentations at two conferences and the initiation of research collaborations Confirms top-line results from the second inarigivir (formerly SB 9200) monotherapy dosing cohort of the ACHIEVE...